Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Akanksha Bakshi

SHOCKING: Rbc capital raises dialogue health technologies price target positive on recent acquisition - What They Never Told You

  • RBC Capital analyst Douglas Miehm raised the price target for Dialogue Health Technologies Inc (TSX:CARE) to C$10 from C$9 with the Sector Perform rating on the shares.
  • Last week CARE announced the acquisition of London, U.K.-based Tictrac Ltd. for up to C$56 million (5.3x 2022E revenues). Tictrac is a SaaS-based provider of a global health and wellness platform that enables healthier living for everyone.
  • Miehm views the Tictrac acquisition positively, as it strengthens Dialogue’s value proposition as a fully integrated digital health platform.
  • Price Action: CARE shares are trading higher by 1.52% at C$6.00 on TSX on the last check Monday.
Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.